Wells Fargo Downgrades NuVasive (NUVA) to Market Perform after Warning
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/18/2026
- Wall Street indexes slip as oil prices rise, retail results awaited
- Trump threatens to bomb Oman over Iran stance
- Why this Wall Street strategist says the "trade is long gold"
- U.S. EV market shows signs of bottoming out: Bernstein
- Micron rises as White House presses Apple to avoid Chinese memory chips
- Wall Street indexes slip as oil prices rise, retail results awaited
- BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
- Micron rises as White House presses Apple to avoid Chinese memory chips
- Trump threatens to bomb Oman over Iran stance
- H.C. Wainwright Reiterates Buy Rating on Soluna (SLNH)
First Analysis Downgrades NuVasive (NUVA) to Equal Weight after Warning
October 4, 2012 9:47 AM EDTFirst Analysis downgraded NuVasive (NASDAQ: NUVA) from Overweight to Equal Weight after last night's warning.
For an analyst ratings summary and ratings history on NuVasive click here. For more ratings news on NuVasive click here.
Shares of NuVasive closed at $22.62 yesterday, with a 52 week range of $11.02-$25.99.... More
Summer Street Downgrades NuVasive (NUVA) to Neutral
October 4, 2012 9:46 AM EDTSummer Street downgraded NuVasive (NASDAQ: NUVA) from Buy to Neutral.
For an analyst ratings summary and ratings history on NuVasive click here. For more ratings news on NuVasive click here.
Shares of NuVasive closed at $22.62 yesterday, with a 52 week range of $11.02-$25.99.... More
Brean Murray Carret & Co. Downgrades NuVasive (NUVA) to Hold on Warning; Globus (GMED), Orthofix (OFIX) Benefit
October 4, 2012 7:04 AM EDTBrean Murray Carret & Co. downgraded NuVasive (NASDAQ: NUVA) from Buy to Hold after last night's warning.
"The miss was due to weakness in the core US Lumbar business (IOM was also weak), but it had less to do with the competitive... More
RBC Capital Downgrades NuVasive (NUVA) to Underperform
October 4, 2012 6:56 AM EDTRBC Capital downgraded NuVasive (NASDAQ: NUVA) from Outperform to Underperform with a price target of $16.00 (from $25.00) after the Q3 warning after the close.
For an analyst... More
BMO Capital Downgrades NuVasive (NUVA) to Underperform after Warning
October 4, 2012 6:54 AM EDTBMO Capital downgraded NuVasive (NASDAQ: NUVA) from Market Perform to Underperform with a price target of $15.00 (from $23.00), after the Q3 warning after the close.
For an... More
NuVasive (NUVA) Guides Q3 Revenues Lower
October 3, 2012 4:07 PM EDTNuVasive, Inc. (NASDAQ: NUVA) announced preliminary unaudited information regarding expected revenue results for the third quarter 2012, which was below its prior views and the Wall Street consensus.
NuVasive anticipates revenue for the third quarter 2012 to be approximately $147 million, which is below the Company's... More
